BAG Diagnostics GmbH of Lich at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Premium Exhibitor Manufacturers Trader

BAG Diagnostics GmbH

Amtsgerichtsstr. 1-5, 35423 Lich
Telephone +49 6404 925-0
Fax +49 6404 925-460

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.


Dr. rer. nat. Ingo Meier

Geschäftsbereichsleiter / Division Manager

+49 (171) 765 8921


Ph Dr. Sona Penickova

Export Manager

+420 (777) 227 439


Dr. rer. nat. Nadine Pavkovic

Außendienst / Sales Representative

+49 (171) 7658911


Frank Lammers


+49 (171) 7658924


Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Visit us

16 Nov 2020


13:20 - 13:50

Ensure high throughput for Flu Season: COVID-19, Flu A, Flu B and RSV - Benedikt Hampen

With the upcoming flu season uncertainty is increasing as to whether the symptoms present are signs of a "normal flu" or a highly contagious SARS-CoV-2 infection. The real time RT-PCR kit presented here detects SARS-CoV-2, Influenza A, Influenza B and RS viruses in only one test. In addition the internal cell control indicates if sufficient cell material for a valid test is present in the sample.

More Less

17 Nov 2020


12:40 - 13:10

Multiplex qPCR HLA genotyping & direct from blood amplification - Mike Bunce, Lena Walter

HISTO TYPE Rainbow offers rapid, highly multiplexed qPCR identification of 11 HLA loci in convenient 96 well PCR format. PlexTyper software enables automated and accurate interpretation of qPCR data.
We will also present our novel FastQ® system for real time PCR direct from blood or DNA. FastQ® enables PCR without DNA extraction as demonstrated with our range of HLA disease association tests.

More Less

19 Nov 2020


12:40 - 13:10

Precision blood group typing with fast and easy real-time PCR - Kira Kirchgessner

Get to know a great solution for your blood group diagnostics. The highly flexible real-time PCR Ery Q blood group typing kits are perfect for even difficult blood samples and deliver the result in less than 70 min. Get to know the kits and convince yourself of the simple application and the easy test setup. The user-friendly software simplifies the evaluation of the results.

More Less

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.03  Polymerase chain reaction (PCR)
  • 03  Diagnostic tests
  • 03.06  Genetic testing, molecular diagnostics
  • 03.06.04  Other molecular diagnostics testing

Our products

Product category: Polymerase chain reaction (PCR), Other molecular diagnostics testing

Blood group real-time PCR

ERY Q kits and Weak D-TYPE 1-2-3 Q
Fast and pinpoint blood group typing!

With our real-time kits we offer the ideal solution for your molecular blood group diagnostics. They are perfect to confirm samples with weak or unclear serological results. The unique kit design gives you a high flexibility and improves your productivity.

This product line is a clever and time-saving alternative to serum based blood group typing!
It gives you precise results in patient and donor typing:

- as a comprehensive solution ERY Q includes kits for ABO, ABO variant, RH, Weak D, Partial D, KKD/ MNS, HNA, HPA.
- if you only need a detection system for weak D types 1, 2 and 3 with the exclusion of weak D type 1.1, we offer Weak D-TYPE 1-2-3 Q, a precisely fitting typing kit.

Both products are based on a molecular genetic method.

More Less

Product category: Other molecular diagnostics testing, Polymerase chain reaction (PCR)

HLA real-time PCR

HISTO TYPE Rainbow is the best solution for easy and fast HLA-typing with low and medium resolution. The kit offers important advantages for your laboratory:

Efficient: All 11 loci typed on one 96 well plate.
Fast: Reduce the time and get the result in less than 80 minutes.
Convenient: User friendly automated interpretation with our PlexTyper software.

Of course, the kits are subject to CE marking according to IVD Directive 98/79/EC. A complete quality assurance according to ISO 13485 characterizes our high demands on the safety of our products.

Evaluation fast and easy
With our PlexTyper® software, specially developed for daily laboratory routine, we ensure simple evaluation of the results. Therefore the raw data from the real-time Cycler are automatically evaluated. For this, software offers fast and intuitive interpretation tools.

More Less

Product category: Polymerase chain reaction (PCR), Other molecular diagnostics testing

Human genetic real-time PCR

FastQ® product line - one solution, many possibilities!

Our new FastQ® product line is designed to give you the choice of using DNA or blood samples according to your needs. These kits offer a high quality solution for disease association typing. Through optimized multiplexing and the use of Taqman® probes we maximize the precision and safety of the FastQ® product line. Both versions – for DNA and for blood samples – take advantage of real-time technology and multiplexing for fast and reliable typing. For reliable results, an internal amplification control is included in each PCR reaction.

You can also take advantage of real-time technology. With multiplex PCR, you also obtain fast and reliable typing results for the following disease associations:
  • M. Bechterew et al.
  • Celiac disease
  • Hemochromatosis - coming soon
Blood Booster for even more safety
Our FastQ® direct line can cope with difficult blood samples (e.g. high EDTA concentration). We have developed the Blood Booster reagent especially for this purpose, which enables very reliable and reproducible results. Simply pipette blood samples diluted and directly. Save valuable time and expensive material.

Laboratories benefit from the advantages of FastQ® direct kits:
  • time-saving: pre-treatment of the blood sample is not necessary
  • easy on the budget: no expensive and time-consuming DNA isolation
  • low risk: low risk of cross-contamination

More Less

Product category: Polymerase chain reaction (PCR), Other molecular diagnostics testing

Virologic real-time PCR

Against the massive spread of the coronavirus SARS-CoV-2, our reliable CE IVD certified tests help to locate infected persons safely. This is the only way to prevent the unchecked spread of the virus.

False negative results, due to insufficient sampling with too little cell material, are excluded by this tests. The detection of a human gene that occurs universally in cells in ViroQ and ViroQ Rapid SARS-CoV-2 tests check whether sufficient cell material is available for valid results.

By the way: With our kits you remain independent from dedicated providers - they work with common RNA-Isolation kits and common real time cyclers. The test results are available in only 90 minutes - with ViroQ Rapid SARS-CoV-2 (thanks to the optimized PCR protocol) in less than 60 minutes.

We have also thought about the logistics costs: To keep them as low as possible, our test kits can be shipped uncooled. A control temperature of - 20 degrees Celsius is only necessary during storage.

Coming Soon: SARS-CoV-2 + New Flu - in only one multiplex PCR- assay!

More Less

Company news



11 Nov 2020

Intelligent typing of disease associations - with the real-time PCR kits of the FastQ® linie directly from blood samples or DNA

Lich, November, 11th 2020 – In order to be able to clearly type disease associations in an even more time- and cost-efficient way, BAG Diagnostics is developing a new product line: With the kits of the FastQ® series, celiac disease, M. Bechterew et al. and Haemochromatosis can be determined quickly and reliably by real-time PCR. It does not have any relevance whether the raw material is present as DNA or blood sample. Thanks to the Blood Booster Reagent developed especially for FastQ®, blood samples can even be easily diluted and pipetted directly. FastQ® B27 direct for typing of M. Bechterew et al. - directly from blood as starting material - is already available. For the typing of M. Bechterew et al. and Celiac disease from DNA the test kits are also already available.
It is no longer conceivable to imagine human genetics without real-time PCR for the typing of disease associations. The new FastQ®-Line from BAG Diagnostics combines the advantages of real-time technology with high-performance multiplex PCR. Within a single PCR approach, genes associated with celiac disease, M. Bechterew et al. and Haemochromatosis can be detected from DNA as well as from blood samples as starting material.
The PCR programme used ensures an optimized workflow: once set up, it can be used for all FastQ® kits. The specificity of the reaction is defined both by the primer sequences and the probe sequence. This increases the resolution and reduces false-positive reactions to a minimum.
Blood Booster – pipette directly from blood
The FastQ® direct kits eliminate the need for time and cost intensive DNA isolation. Thanks to the specially developed Blood Booster Reagent, the advanced real-time assays allow PCR amplification directly from diluted blood samples. The stabilising effect of the reagent allows absolutely safe and reproducible results even with very fresh and difficult blood samples (e.g. with a high EDTA concentration).
Minimised Hands-On-Time
Depending on the starting material - DNA or blood samples - results are available after 60 or 90 minutes. Ready-to-use standard reagents and optimised multiplexing ensure a high data throughput. For reliable results, an internal amplification control is included in every PCR approach.
Optimised workflow
Real-time PCR works without gels and guarantees a simple workflow and safe handling. Cost-intensive disposal of environmentally harmful toxic residues is not necessary. Working with closed reaction vessels after amplification also prevents contamination in the post-PCR area.
Already available test kits of the FastQ®-productline:
Amplification from DNA:
M. Bechterew et al.
Coeliac disease
FastQ® B*27
FastQ® CD

Amplification from whole blood:
 M. Bechterew et al.
FastQ® B*27 direct
The kits FastQ® HFE and FastQ® HFE direct for typing for Haemochromatosis and the FastQ® direct-variant for typing for Celiac disease will be available shortly.
Detailed information:
This text has 2,985 characters including spaces. Further information and a wide variety of images are available in electronic form at A specimen copy to the agency is requested.

More Less

23 Oct 2020

Influenza, Corona, RS-Virus? Fast response in only one PCR run with ViroQ SARS-FluA/B-RSV

Lich, October 23th 2020 – "Normal" flu, RSV infection or CORONA? This is a question that preoccupies patients and healthcare staff in autumn and winter equally. The newly developed PCR rapid test from BAG Diagnostics provides a quick answer. ViroQ SARS-FluA/B-RSV detects in just one PCR run whether the samples present contain SARS-CoV-2, RS, influenza A or B viruses. In addition, as with the pure corona test ViroQ SARS-CoV-2, the real-time kit indicates whether sufficient cell material for valid test results is contained in the samples from throat and nose swabs.
Autumn is flu season. For many people, uncertainty is increasing as to whether the symptoms present are signs of a "normal flu" or a highly contagious SARS-CoV-2 infection causing COVID-19. BAG Diagnostics, specialised in the development and distribution of in-vitro diagnostics, has further developed its successful PCR rapid test ViroQ SARS-CoV-2: In just one PCR run, laboratories can reliably detect whether tracheal secretion / sputum samples contain SARS-CoV-2, RS, influenza A or B viruses.
The test also shows whether there is sufficient cell material available for valid test results. Incorrectly reported negative results, which occur in conventional tests due to too little material in the samples taken, can be avoided with the new BAG kit.
Fast and flexible to use
Ready-to-use standard reagents and an optimised one-step PCR run ensure high throughput in laboratories. Test results are available after only 60 minutes.
With ViroQ SARS-FluA/B-RSV, laboratories remain independent of suppliers. The rapid test can be combined with common RNA isolation kits. It is designed for use with commercially available real-time PCR instruments.
"During development, it was also very important to us to create a product that could address the needs of patients, physicians and laboratories alike. So on the one hand, another focus was on delivering fast and reliable results. We succeeded in doing this with an optimised PCR protocol. This saves us a good half hour compared to conventional products. That means at least one more complete PCR run per day. On the other hand, we wanted to create conditions for immediate use - in other words, no binding to a specific hardware or other components," explains Dr. Ingo Meier, Division Manager BAG Diagnostics.
Cost-effective shipping
Diagnostics that require permanent cooling are considerably more expensive in terms of logistics. The new test kit has therefore been designed so that it can be shipped uncooled. This ensures that the quality is not affected by temperature fluctuations.
The test is available immediately. Detailed information:
This text has 2,271 characters including spaces. Further information and a wide variety of images are available in electronic form at A specimen copy to the agency is requested.

More Less

14 Oct 2020

ViroQ Rapid SARS-CoV-2 – for faster results

Lich, October, 14th 2020 – To enable an even more efficient sample throughput, BAG Diagnostics GmbH has perfected its well-established real-time PCR kit for the detection of SARS-CoV-2: With ViroQ Rapid SARS-CoV-2, valid results are now available after less than 60 minutes instead of 90 minutes. The optimized PCR protocol enables laboratories to evaluate an entire test run more per day.

The increasing number of people infected with the corona virus worldwide requires a high volume of reliable rapid tests. In order to deliver valid results quickly, the established German company BAG Diagnostics has optimized the PCR protocol of the certified rapid test ViroQ SARS-CoV-2. With ViroQ Rapid SARS-CoV-2, laboratories can now make statements on the available sample material in less than 60 minutes.

Fast One-Step Real-time PCR
ViroQ Rapid SARS-CoV-2 is designed for the specific detection of the viral RNA genes E and RdRP of SARS-CoV-2 from throat/nose swabs. In the test kit the RNA is transcribed from SARS-CoV-2 (COVID-19) to cDNA in the first step of the PCR protocol. This cDNA is amplified in the same, now optimized real-time PCR protocol. The modified PCR protocol is applicable to both kit variants of ViroQ. The fluorescent dyes used are compatible with the common real-time cyclers. Therefore, laboratories remain independent from dedicated providers.

Cell material check for valid test results
The tapping of tracheal secretion and sputum is a difficult procedure: If one proceeds too forcefully, blood impurities can worsen the performance. If you are too reluctant, you will get an inadequate tap with too less cell material. To make sure that there is enough cell material for a detection, the ViroQ Rapid SARS-CoV-2 kit checks whether a human gene that is universally existing in cells is present in sufficient quantity. The PCR test excludes false negative results caused by insufficient samples.

No cooling for transport
The ViroQ Rapid SARS-CoV-2 test kits – just like the ViroQ SARS-CoV-2 variant – can be shipped uncooled. A control temperature of -20 degrees Celsius is only necessary for storage.

The test is available immediately. Detailed information:

This text has 2,271 characters including spaces. Further information and a wide variety of images are available in electronic form at A specimen copy to the agency is requested.

More Less

About us

Company portrait

BAG - more safety in medical care - Made in Germany
BAG - owner-managed in third generation since 1947 - feels committed to safety in medical treatment. Today, BAG Diagnostics operates worldwide as a leading supplier of in-vitro diagnostics.
Laboratories, blood donation services, clinics and physicians appreciate our entrepreneurial flexibility, the innovative power and the distinctive quality awareness. Based on our solid scientific and technical expertise, we develop innovative, tailor-made products in our in-house laboratories - Made in Germany.
Our test systems and reagents stand for reliable diagnoses and treatments in human genetics as well as in infectiology, transfusion- and transplantation medicine.

Company data

Sales volume 1-9 Mio US $
Export content max. 75%
Number of employees 50-99
Foundation 2019
Area of business Diagnostics

Company information as a PDF file